Trial Profile
Analysis of efficacy and safety of antiviral therapy with simeprevir, peginterferon and ribavirin for recurrent hepatitis C after liver transplantation
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2014
Price :
$35
*
At a glance
- Drugs Peginterferon (Primary) ; Ribavirin (Primary) ; Simeprevir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 20 Dec 2013 New trial record